Document is current
Any future updates will be listed below
-
Authors
Mehta, Hemal https://orcid.org/0000-0002-0606-9004
- License Information
-
More Information
Article History
Received: 11 March 2026
Revised: 12 March 2026
Accepted: 16 March 2026
First Online: 4 April 2026
Competing interests
: HM has served as a consultant for Alcon, AbbVie, Apellis, Astellas, Bayer, Boehringer Ingelheim, Ripple Therapeutics and Roche, and is a member of the Eye editorial board.
Free to read: This content has been made available to all.
